SCHEMBL4558231

SCHEMBL4558231

Oc1[nH]c2ccccc2c1-c1ccc(CN2CCOCC2)cn1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 2/20 0.70
DYRK3 O43781 1/20 0.70
CDK1 P06493 1/20 0.70
GSK3B P49841 1/20 0.70
CDK7 P50613 1/20 0.70
CDK5 Q00535 1/20 0.70
CAMK2G Q13555 1/20 0.70
MARK2 Q7KZI7 1/20 0.70
PIM3 Q86V86 1/20 0.70
MINK1 Q8N4C8 1/20 0.70
PRKD2 Q9BZL6 1/20 0.70
CLK4 Q9HAZ1 1/20 0.70
SGK2 Q9HBY8 1/20 0.70
STK17A Q9UEE5 1/20 0.70
CAMK2A Q9UQM7 1/20 0.70
DYRK1B Q9Y463 1/20 0.70
MAPT P10636 3/20 0.53
GAA P10253 2/20 0.53
PARP1 P09874 1/20 0.46
ALDH1A1 P00352 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL477994 0.87 DYRK3 (0.64) CDK2DYRK3CDK1GSK3BCDK7
SCHEMBL4064506 0.85 CDK1 (0.65) CDK2DYRK3CDK1GSK3BCDK7
SCHEMBL4069900 0.85 CDK1 (0.74) CDK2DYRK3CDK1GSK3BCDK7
SCHEMBL10079716 0.85 CDK7 (0.74) CDK2DYRK3CDK1GSK3BCDK7
SCHEMBL477976 0.84 CDK2 (0.59) CDK2DYRK3CDK1GSK3BCDK7
Hydrochloric Acid SCHEMBL4057891 0.84 CDK1 (0.64) CDK2DYRK3CDK1GSK3BCDK7
Hydrochloric Acid SCHEMBL4066580 0.84 CDK1 (0.72) CDK2DYRK3CDK1GSK3BCDK7
SCHEMBL4061413 0.84 CDK1 (0.69) CDK2DYRK3CDK1GSK3BCDK7
Hydrochloric Acid SCHEMBL4064202 0.83 CDK1 (0.68) CDK2DYRK3CDK1GSK3BCDK7
SCHEMBL396747 0.83 DYRK3 (0.50) CDK2DYRK3CDK1GSK3BCDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009017455-A1 A NEW COMBINATION OF (A) AN ALPHA-4-BETA-2 -NEURONAL NICOTINIC AGONIST AND (B) A GSK3 INHIBITOR ASTRAZENECA AB (SE) 2009-02-05 WO disclosed